MA39899A - USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDG) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION AND CHEMICAL DAMAGE - Google Patents

USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDG) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION AND CHEMICAL DAMAGE

Info

Publication number
MA39899A
MA39899A MA039899A MA39899A MA39899A MA 39899 A MA39899 A MA 39899A MA 039899 A MA039899 A MA 039899A MA 39899 A MA39899 A MA 39899A MA 39899 A MA39899 A MA 39899A
Authority
MA
Morocco
Prior art keywords
sdg
protection against
related compounds
chemical damage
against radiation
Prior art date
Application number
MA039899A
Other languages
French (fr)
Inventor
Melpo Christofidou-Solomidou
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of MA39899A publication Critical patent/MA39899A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
MA039899A 2014-05-30 2015-06-01 USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDG) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION AND CHEMICAL DAMAGE MA39899A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462005330P 2014-05-30 2014-05-30
US201562101296P 2015-01-08 2015-01-08

Publications (1)

Publication Number Publication Date
MA39899A true MA39899A (en) 2021-05-26

Family

ID=54700083

Family Applications (1)

Application Number Title Priority Date Filing Date
MA039899A MA39899A (en) 2014-05-30 2015-06-01 USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDG) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION AND CHEMICAL DAMAGE

Country Status (9)

Country Link
EP (1) EP3148560A4 (en)
JP (2) JP2017520620A (en)
KR (1) KR20170010019A (en)
CN (2) CN107155304A (en)
AU (2) AU2015266614A1 (en)
CA (1) CA2950744A1 (en)
IL (1) IL249219A0 (en)
MA (1) MA39899A (en)
WO (1) WO2015184441A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11071746B2 (en) 2016-06-07 2021-07-27 The Trustees Of The University Of Pennsylvania Compositions and methods for protecting organs from ischemia/reperfusion injury associated with transplantation
EP3606325B1 (en) * 2017-04-03 2024-09-04 Gusto Global, LLC Rational design of microbial-based biotherapeutics
US20200268779A1 (en) * 2017-09-27 2020-08-27 The Trustees Of The University Of Pennsylvania USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION-INDUCED CARDIOVASCULAR DYSFUNCTION
US20210128596A1 (en) * 2017-09-27 2021-05-06 University Of Pennsylvania Compositions and methods for treating septic cardiomyopathy
EP3843557B1 (en) * 2018-08-31 2023-09-20 Innophos, LLC An extract of anacardium occidentale for use in treating oxidation induced dna damage
CN116850162A (en) * 2023-08-08 2023-10-10 南通大学附属医院 Application of enterodiol in preparation of medicine for treating radiation enteritis
CN121094806B (en) * 2025-11-07 2026-02-24 深圳鼎智通讯股份有限公司 An Android SoftPOS trusted application method and application system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486126B1 (en) * 1999-06-30 2002-11-26 University Of Saskatchewan Technologies Incorporated Antioxidant activity in SDG metabolites
EP1414436A1 (en) * 2000-06-14 2004-05-06 Alla Shapiro Radioprotective agents
CN100365005C (en) * 2006-03-02 2008-01-30 江南大学 A method for extracting and purifying secoisolariciresinol diglucoside from linseed
US20070293458A1 (en) * 2006-06-16 2007-12-20 Ip-6 Research Inc. Prevention of nuclear, solar, and other radiation-induced tissue damage
US10449224B2 (en) * 2007-05-25 2019-10-22 The Trustees Of The University Of Pennsylvania Flaxseed lignan complex, methods of using and compositions thereof
AU2009279676C1 (en) * 2008-08-07 2015-08-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Radioprotectants targeting thrombospondin-1 and CD47
CN101759731B (en) * 2008-12-25 2011-10-19 中国科学院兰州化学物理研究所 Extraction method of linseed gum and secoisolariciresin-ol diglucoside
PT3007557T (en) * 2013-06-10 2018-11-09 Scripps Research Inst Preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside

Also Published As

Publication number Publication date
EP3148560A2 (en) 2017-04-05
AU2015266614A1 (en) 2016-12-15
WO2015184441A3 (en) 2016-03-10
CA2950744A1 (en) 2015-12-03
CN112336736A (en) 2021-02-09
AU2020270469A1 (en) 2020-12-17
JP2017520620A (en) 2017-07-27
WO2015184441A9 (en) 2016-01-21
EP3148560A4 (en) 2018-04-25
WO2015184441A2 (en) 2015-12-03
CN107155304A (en) 2017-09-12
JP2020121987A (en) 2020-08-13
IL249219A0 (en) 2017-02-28
KR20170010019A (en) 2017-01-25

Similar Documents

Publication Publication Date Title
GB2558826B (en) Mitigation of anti-sandbox malware techniques
EP3474845A4 (en) IMMUNOMODULATORY COMPOUNDS
EP2969770A4 (en) SHOCK PROTECTION APPARATUS
DK3119762T3 (en) BENZIMIDAZOLE DERIVATIVES AS ERBB-TYROSINE CHINASE INHIBITORS FOR THE TREATMENT OF CANCER
EP3161714A4 (en) Mitigation of malware
MA39899A (en) USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDG) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION AND CHEMICAL DAMAGE
DK3256853T3 (en) PREDICTION OF T-CELL PITOPES SUITABLE FOR VACCINATION
DK3466432T3 (en) PROCEDURES FOR THE TREATMENT OF PULMONAL NON-TUBERCULOSE MICOBACTERIAL INFECTIONS
MA46373A (en) COMPOUNDS USED AS MMR GAMMA MODULATORS
DK3148529T3 (en) COMPOUNDS FOR THE TREATMENT OF BRAIN CANCER
DK3160927T3 (en) PROCEDURE FOR THE PREPARATION OF ETHYLENE GLYCOL FROM SUGAR
KR20180084990A (en) Process and reactor for the epoxidation of propene
DK3180329T3 (en) TRIAZOLES AS NR2B RECEPTOR INHIBITORS
PL3288532T3 (en) Polymers for the stabilisation of peroxide compounds
HUE058257T2 (en) Processes for the preparation of oxathiazine compounds
PL3400269T3 (en) Use of 4-bora-3a, 4a-diaza-s-indacen for protection
DK3360117T3 (en) PROCEDURE FOR MONITORING CONFORMITY OF PERSONAL SAFETY EQUIPMENT
EP3314509A4 (en) Mitigation of malware
MA49623A (en) CHEMICAL COMPOUNDS
EP3337804A4 (en) BIOCONJUGATES OF HETEROCYCLIC COMPOUNDS
HUE042043T2 (en) Triaminopyridine compounds for the prophylaxis or treatment of malaria
HUE045704T2 (en) Process for the preparation of 5-fluoro-1H-pyrazoles from hexafluoropropene
GB2543602B (en) Mitigation of anti-sandbox malware techniques
PL4012035T3 (en) ADENOVIRUS-RELATED VIRAL VECTORS FOR THE TREATMENT OF MYOCILLOIDAL GLAUCOMA (MYOC)
DK3171926T3 (en) Safety connector for medical devices